Who we are

The emerging biotech council is a place for leaders from emerging biopharma companies to connect, collaborate, and learn from each other and drive commercial success for their organizations.

The council comprises of leaders from emerging biopharma, digital health, and digital therapeutics companies who advance the healthcare system through transformative science, technology and innovative commercialization models.

What drives us

Mission

Build a trusted and confidential environment for leaders from emerging biopharma enterprises to connect and collaborate on innovation and spur commercial success

Vision

To enable emerging biopharma enterprises to jointly discover ways to re-think capabilities, leverage innovative business models, and reduce reliance on traditional systems

Members

Anil Namboodiripad

Anil Namboodiripad

SVP, Proprietary Products, & President - Promius Pharma
Alok Sonig

Alok Sonig

CEO, Generics and Global Head, Generics R&D & Biosimilars, Lupin
Anish Dhanarajan

Anish Dhanarajan

Co-founder and CEO, Vici Health Sciences
Dr. David Lennon

Dr. David Lennon

President AveXis, a Novartis Company
Dror Bashan

Dror Bashan

President & CEO, Protalix Biotherapeutics
Greg Divis

Greg Divis

CEO, Avadel Pharmaceuticals
Mark Simon

Mark Simon

Partner and Co-Founder, Torreya Investment Bank
Reginald Seeto

Reginald Seeto

President & CBO, CareDx
Sanjeev L

Sanjeev L

President and CEO, Rafael Pharmaceuticals
Shane J. Schaffer

Shane J. Schaffer

Chairman & CEO, Cingulate Therapeutics
Sharon Cunningham

Sharon Cunningham

Chief Commercial Officer, Bioxcel Therapeutics
Subhasis Banerji

Subhasis Banerji

Founder & Managing Director, SynPhNe
Sunil Bhonsle

Sunil Bhonsle

President & CEO, Titan Pharmaceuticals
Vijay Shreedhar

Vijay Shreedhar

Chief Commercial Officer, Adamas Pharmaceuticals
Will Kane

Will Kane

Chief Commercial Officer, Bioxcel Therapeutics
Abhay Gandhi

Abhay Gandhi

CEO - North America, Sun Pharma